Allogeneic chondrogenically differentiated human mesenchymal stromal cells do not induce immunogenic responses from T lymphocytes in vitro

Cytotherapy

Volumn 18, Issue 8, 2016, Pages 957-969

  Kiernan, Caoimhe H ^a,b   Hoogduijn, Martin J ^b   Franquesa, Marcella ^b   Wolvius, Eppo B ^b   Brama, Pieter A J ^a   Farrell, Eric ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

allogeneic; chondrogenic mesenchymal stromal cells; endochondral; immunomodulation; T cells

Indexed keywords

CARBOXYFLUORESCEIN; CD3 ANTIBODY; COMPLEMENTARY DNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL INTERACTION; CELL ISOLATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MESENCHYMAL STROMA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TISSUE ENGINEERING; UPREGULATION; ALLOTRANSPLANTATION; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CHONDROCYTE; CHONDROGENESIS; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MONONUCLEAR CELL; PHYSIOLOGY;

BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; COCULTURE TECHNIQUES; HUMANS; IMMUNOMODULATION; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84973535608     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2016.05.002     Document Type: Article

References (35)

1. [1] Mackie, E.J., Ahmed, Y.A., Tatarczuch, L., Chen, K.S., Mirams, M., Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40:1 (2008), 46–62.
2. [2] Farrell, E., Both, S.K., Odorfer, K.I., Koevoet, W., Kops, N., O'Brien, F.J., et al. In-vivo generation of bone via endochondral ossification by in-vitro chondrogenic priming of adult human and rat mesenchymal stem cells. BMC Musculoskelet Disord, 12, 2011, 31.
3. [3] Huang, J.I., Durbhakula, M.M., Angele, P., Johnstone, B., Yoo, J.U., Lunate arthroplasty with autologous mesenchymal stem cells in a rabbit model. J Bone Joint Surg Am 88:4 (2006), 744–752.
4. [4] Gawlitta, D., Farrell, E., Malda, J., Creemers, L.B., Alblas, J., Dhert, W.J., Modulating endochondral ossification of multipotent stromal cells for bone regeneration. Tissue Eng Part B Rev 16:4 (2010), 385–395.
5. [5] Janicki, P., Kasten, P., Kleinschmidt, K., Luginbuehl, R., Richter, W., Chondrogenic pre-induction of human mesenchymal stem cells on beta-TCP: enhanced bone quality by endochondral heterotopic bone formation. Acta Biomater 6:8 (2010), 3292–3301.
6. [6] Meijer, G.J., de Bruijn, J.D., Koole, R., van Blitterswijk, C.A., Cell based bone tissue engineering in jaw defects. Biomaterials 29:21 (2008), 3053–3061.
7. [7] Chatterjea, A., Meijer, G., van Blitterswijk, C., de Boer, J., Clinical application of human mesenchymal stromal cells for bone tissue engineering. Stem Cells Int, 2010, 2010, 215625.
8. [8] Tasso, R., Augello, A., Boccardo, S., Salvi, S., Carida, M., Postiglione, F., et al. Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A 15:8 (2009), 2203–2212.
9. [9] Tasso, R., Fais, F., Reverberi, D., Tortelli, F., Cancedda, R., The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Biomaterials 31:8 (2010), 2121–2129.
10. [10] Tortelli, F., Tasso, R., Loiacono, F., Cancedda, R., The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials 31:2 (2010), 242–249.
11. [11] Chan, C.K., Chen, C.C., Luppen, C.A., Kim, J.B., DeBoer, A.T., Wei, K., et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 457:7228 (2009), 490–494.
12. [12] Liu, Y., Wang, L., Kikuiri, T., Akiyama, K., Chen, C., Xu, X., et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat Med 17:12 (2011), 1594–1601.
13. [13] Mougiakakos, D., Jitschin, R., Johansson, C.C., Okita, R., Kiessling, R., Le Blanc, K., The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117:18 (2011), 4826–4835.
14. [14] Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:9 (2003), 3722–3729.
15. [15] Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:10 (2002), 3838–3843.
16. [16] Ryan, A.E., Lohan, P., O'Flynn, L., Treacy, O., Chen, X., Coleman, C., et al. Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation. Mol Ther 22:3 (2014), 655–667.
17. [17] Cuerquis, J., Romieu-Mourez, R., Francois, M., Routy, J.P., Young, Y.K., Zhao, J., et al. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-gamma and tumor necrosis factor-alpha stimulation. Cytotherapy 16:2 (2014), 191–202.
18. [18] Engela, A.U., Baan, C.C., Litjens, N.H., Franquesa, M., Betjes, M.G., Weimar, W., et al. Mesenchymal stem cells control alloreactive CD8(+) CD28(−) T cells. Clin Exp Immunol 174:3 (2013), 449–458.
19. [19] Sensebe, L., Bourin, P., Mesenchymal stem cells for therapeutic purposes. Transplantation 87:Suppl. 9 (2009), S49–53.
20. [20] Aggarwal, S., Pittenger, M.F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:4 (2005), 1815–1822.
21. [21] Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:1 (2002), 42–48.
22. [22] Roemeling-van Rhijn, M., Khairoun, M., Korevaar, S.S., Lievers, E., Leuning, D.G., Ijzermans, J.N., et al. Human bone marrow- and adipose tissue-derived mesenchymal stromal cells are immunosuppressive and in a humanized allograft rejection model. J Stem Cell Res Ther(Suppl. 6(1)), 2013, 20780.
23. [23] Di Ianni, M., Del Papa, B., De Ioanni, M., Moretti, L., Bonifacio, E., Cecchini, D., et al. Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol 36:3 (2008), 309–318.
24. [24] Melief, S.M., Schrama, E., Brugman, M.H., Tiemessen, M.M., Hoogduijn, M.J., Fibbe, W.E., et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells 31:9 (2013), 1980–1991.
25. [25] English, K., Ryan, J.M., Tobin, L., Murphy, M.J., Barry, F.P., Mahon, B.P., Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol 156:1 (2009), 149–160.
26. [26] Ye, X., Yin, X., Yang, D., Tan, J., Liu, G., Ectopic bone regeneration by human bone marrow mononucleated cells, undifferentiated and osteogenically differentiated bone marrow mesenchymal stem cells in beta-tricalcium phosphate scaffolds. Tissue Eng Part C Methods 18:7 (2012), 545–556.
27. [27] Bruder, S.P., Kurth, A.A., Shea, M., Hayes, W.C., Jaiswal, N., Kadiyala, S., Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16:2 (1998), 155–162.
28. [28] Scotti, C., Piccinini, E., Takizawa, H., Todorov, A., Bourgine, P., Papadimitropoulos, A., et al. Engineering of a functional bone organ through endochondral ossification. Proc Natl Acad Sci USA 110:10 (2013), 3997–4002.
29. [29] van der Stok, J., Koolen, M.K., Jahr, H., Kops, N., Waarsing, J.H., Weinans, H., et al. Chondrogenically differentiated mesenchymal stromal cell pellets stimulate endochondral bone regeneration in critical-sized bone defects. Eur Cell Mater 27 (2014), 137–148 discussion 48.
30. [30] Zheng, Z.H., Li, X.Y., Ding, J., Jia, J.F., Zhu, P., Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology (Oxford) 47:1 (2008), 22–30.
31. [31] Hoogduijn, M.J., Popp, F., Verbeek, R., Masoodi, M., Nicolaou, A., Baan, C., et al. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol 10:12 (2010), 1496–1500.
32. [32] Quaedackers, M.E., Baan, C.C., Weimar, W., Hoogduijn, M.J., Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes. Eur J Immunol 39:12 (2009), 3436–3446.
33. [33] Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A.I., et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:2 (2008), 141–150.
34. [34] Chen, L., Tredget, E.E., Wu, P.Y., Wu, Y., Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE, 3(4), 2008 e1886.
35. [35] Salti, S.M., Hammelev, E.M., Grewal, J.L., Reddy, S.T., Zemple, S.J., Grossman, W.J., et al. Granzyme B regulates antiviral CD8+ T cell responses. J Immunol 187:12 (2011), 6301–6309.